Device Trial Radar · NCT04798261
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
Last checked: Nov 20, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,500
Planned (sponsor's estimate)
Start
Jun 25, 2021
Primary completion
Dec 2026
Study completion Feb 2028
Sponsor
- Lead sponsor
- Penumbra Inc.Public (PEN)
- Sponsor type
- Industry
- First posted
- Mar 15, 2021
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate real world long-term functional outcomes, safety and performance of the Indigo Aspiration System for the treatment of pulmonary embolism (PE).
Conditions
- Pulmonary Embolism
Interventions
Indigo Aspiration SystemDevice
Indigo Aspiration System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety: Composite of major adverse eventsTime frame: 48 hours
- Performance: Change in RV/LV RatioTime frame: 48 hours post-procedure
Locations
79 sites in 12 countries. Site status is shown where the registry gives one.
Long Beach Medical Center
Long Beach, California · Recruiting
Cedars-Sinai Medical Center
Los Angeles, California · Recruiting
UCLA Medical Center
Los Angeles, California · Recruiting
76 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.